The original article can be found here.
Article highlights:
- Remgro’s profits more than doubled to R6.5 billion to end-June, amid a strong performance from Mediclinic and Distell, while CIVH returned to profit.
- The firm upped its total dividend by more than two thirds, while intrinsic net asset value per share climbed more than a fifth.
- But the group’s discount widened 3.6 percentage points to 39%, and the firm is busy shaking up its portfolio.
